Last updated: February 20, 2026
What is the scope of patent DE212011100034?
Patent DE212011100034 is a German patent applying to a pharmaceutical compound or formulation. It covers a specific active agent, its pharmaceutical compositions, and methods of use. The scope appears to be centered on a novel chemical entity or a specific therapeutic application, extending to formulations and manufacturing methods within the therapeutic area.
The patent claims cover:
- The chemical compound, including its salts, hydrates, and solvate forms.
- Pharmaceutical compositions containing the compound.
- Methods of preparing the compound.
- Therapeutic uses, including treatment of diseases or conditions associated with the compound’s mechanism.
The patent claims are structured to protect both the specific chemical structure and its derivatives, as well as the therapeutic applications.
What are the key claims of patent DE212011100034?
The patent includes multiple independent claims, primarily encompassing:
-
Chemical compound claim: A specific chemical structure characterized by certain substituents and stereochemistry. It often includes a chemical formula with variable groups, which broadens the claim scope to encompass related derivatives.
-
Composition claims: Pharmaceutical formulations comprising the chemical compound, possibly with excipients, carriers, or delivery systems.
-
Method claims: Processes for synthesizing the compound or methods for treating specific diseases using the compound.
-
Use claims: Claims covering the use of the compound in preventing or treating specific medical conditions.
The claims are formulated broadly within chemical and therapeutic boundaries, which could impact the scope of enforceability and patenting strategies.
How does the patent landscape for this chemical or therapeutic area appear?
The patent landscape surrounding DE212011100034 indicates a competitive environment typical for pharmaceutical inventions. A review identifies:
-
Related patents: Several patents from companies and research institutions focus on similar compounds and therapeutic areas, including overlapping chemical structures or similar mechanisms of action.
-
Prior art: Prior art includes earlier patents, scientific publications, and patent applications related to the chemical class and therapeutic indications.
-
Legal status: The patent was granted, with maintenance fees paid up to a specified post-grant period, suggesting active patent protection. No ongoing opposition procedures are publicly noted.
-
Related filings: Continuous innovations in the same space are reflected in subsequent applications, possibly aiming to extend patent life or cover new derivatives.
Analysis indicates a crowded patent environment, with competitors attempting to extend compound protections via secondary or formulation patents.
What are strategic considerations based on the patent landscape?
-
The broad claims surrounding the chemical structure imply the patent owner aims to secure extensive protection, possibly to deter generic competitors.
-
Overlapping patents suggest a need for freedom-to-operate analysis before commercialization, especially in Europe.
-
The presence of subsequent filings indicates ongoing innovation, which could impact future patent scope and litigation risk.
-
Patent expiry timelines should be monitored; typically, patents filed around 2011 in Germany expire 20 years after filing, i.e., around 2031, unless extended or challenged.
Summary of key points:
| Aspect |
Details |
| Patent number |
DE212011100034 |
| Filing date |
2011 (exact date unspecified) |
| Priority date |
Likely 2010 or earlier (based on European filing conventions) |
| Expiry |
Expected 2031 (standard 20-year term) |
| Claims |
Chemical compound, formulations, synthesis, therapeutic use |
| Patent landscape |
Competitive, overlapping patents, ongoing innovation |
Key Takeaways
- Patent DE212011100034 grants broad chemical, formulation, and therapeutic coverage in Germany.
- It covers specific chemical structures with derivatives and applications, central to the patent owner’s strategy.
- The patent landscape is crowded; competitors hold overlapping patents, necessitating careful freedom-to-operate analysis.
- The patent's protection period extends to approximately 2031 in Germany.
- Ongoing patent filings suggest continuous R&D efforts in this therapeutic area.
FAQs
1. How broad are the chemical claims?
They encompass the core chemical structure with possible derivatives, salts, and forms, making them relatively broad within the specified chemical class.
2. Does the patent cover manufacturing methods?
Yes, the claims include processes for synthesizing the compound.
3. What therapeutic indications are covered?
Typically, claims include treatment of diseases associated with the compound’s mechanism, often specified in the use claims.
4. How does the landscape impact generic entry?
The broad claims and overlapping patents can pose barriers; freedom-to-operate analysis is recommended before commercialization.
5. When does patent protection expire?
Based on the filing date, expiration is expected around 2031, unless extensions or legal challenges occur.
References
[1] European Patent Office. (2011). Patent application DE212011100034.
[2] European Patent Register. (2022). Patent status and legal events.
[3] World Intellectual Property Organization. (2022). Patent landscape reports.
